Madam Speaker, we on this side of the House accept the Speaker's guidance on the motions that have been forwarded on report stage debate. The Speaker has accepted two technical motions brought forward by the government to amend Bill C-10. These amendments flow from the amendments that were made by the special committee and will make the bill a better bill while maintaining it, in each case the intention of the Special Committee on the Non-Medical Use of Drugs.
The amendments were proposed by the government after it had the opportunity to consider the amendments that were made by the special committee. Members are aware that, in the somewhat unusual circumstances of last October, the special committee did not feel that it had time to wait until another day for the government to present amendments to implement the changes it wanted. Thus, we have those amendments before us today.
Accordingly, the amendments were drafted in some haste on the night when the special committee began its clause by clause review of the bill. It is therefore not surprising that these technical amendments that we have today are necessary to consider the wording of the amendments made by the special committee. The government believes that the improvements to the wording can and should be made.
I will walk hon. members through the amendments so they will be able to vote on them with a full understanding of their implications. I am confident that members will then support the changes.
The first technical amendment is to clause 3.1. The special committee added a prohibition regarding the disclosure to a foreign government or an international organization or their agents of information relating to a cannabis contravention offence maintained by the Royal Canadian Mounted Police or by an organization having a law enforcement role unless the disclosure is required by a court order. Violation of the prohibition would be a summary conviction offence.
The wording adopted by the special committee is somewhat imprecise and vague. Reference to “other law enforcement information systems” and “organizations having a law enforcement role” are vague and need to be clarified. The government's proposed amendment would bring added clarity and precision to the text. However there is a very important change suggested.
The wording of the bill currently refers to “an agent of a foreign government”. The concern is that “agent”, which is undefined, could be interpreted quite narrowly. Therefore the government believes that the special committee's intent to foreclose unauthorized disclosure to anyone of information regarding tickets would be best accomplished by replacing “agent” with “a person who acts in the name of or on behalf of such a government or organization”.
The next amendments deal with the review of the provisions of the act. Members of the special committee heard conflicting testimony about the consequences of moving to a ticketing regime. They also heard from some witnesses that the increased penalties provided for major grow ops would have little effect in part because the courts would not respond to the signal provided by Parliament and that the offence of cultivation was to be treated very seriously. Some witnesses called for mandatory terms of imprisonment.
Given the importance of the changes which Bill C-10 is making in the way we would punish the possession of a relatively small amount of marijuana and in the way we would treat the cultivation of marijuana, the government fully accepts that there is a need for the review but the question is how best to ensure in law that the review will take place. The amendment of the committee is somewhat imprecise and vague.
The expression “national drug strategy”, for instance, is undefined in the bill. We know there is enough national drug strategy, announced by the government, and $245 million would be devoted to fighting drug abuse over five years. However, in law, the national drug strategy is not specifically existing.
Moreover, the term “government” is not defined in the Controlled Drugs and Substances Act as it is in some other acts. To rectify this, the government is proposing an amendment that would bring added clarity and precision to the text and make it more effective in four ways.
First, the responsibility to appoint someone to carry out the review is placed squarely on the shoulders of the minister who is charged with the administration of the Controlled Drugs and Substances Act and who has the primary responsibility for Canada's drug strategy, and that would be the Minister of Health.
Second, the scope of the review was significantly expanded. The provision in the bill currently calls for a review of the “Alternative in Penalties”, which refers only to the ticketing regime. The proposed change will cover “the provisions and operation of the act”. This means that the report should cover the effects of the increased penalties for grow ops.
Third, the existing provision provides no timeline for the completion of the review. In theory, the mere appointment of the reviewer of the act would constitute compliance with the provision. If this amendment is accepted the review will have to be completed and submitted to the minister within one year of the appointment.
Fourth, the minister of the day will be obliged to table the report in both Houses of Parliament within 30 sitting days after receiving it.
Clearly the process that is proposed in these amendments is preferable to the process currently in Bill C-10. I put these motions and their explanations before the House for its consideration.